Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis,”1 published online first on May 10, 2019, there were errors in Figure 1 and in Table 3. In Figure 1, the width of the graphed line for the “infliximab optum” row should go to 8.02. In Table 3, all instances of “NA” should be deleted in the Reference Group (MTX), No., Pooled Patients column and in the Exposure Group, No., Pooled Patients column and replaced with the corresponding numbers of pooled patients. This article was corrected online.
Errors in Figure 1 and Table 3. JAMA Dermatol. 2019;155(7):865. doi:10.1001/jamadermatol.2019.1723
Artificial Intelligence Resource Center